Vita 34 AG
XETRA:V3V
Vita 34 AG
XETRA:V3V
Price:
4.7 EUR
-1.26%
Market Closed
Updated:
May 9, 2024
Vita 34 AG
Operating Expenses
|
Vita 34 AG
Operating Expenses Peer Comparison
Comparables:
F
FME
F
FRE
E
1846
SYAB
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vita 34 AG
XETRA:V3V
|
Operating Expenses
-€32.8m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-17%
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Operating Expenses
-€3.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-6%
|
|
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Operating Expenses
-€3.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-1%
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Operating Expenses
-HK$141.4m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Synlab AG
XETRA:SYAB
|
Operating Expenses
-€1.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Operating Expenses?
Operating Expenses
-32.8m
EUR
-32.8m
EUR
Based on the financial report for Sep 30, 2023, Vita 34 AG's Operating Expenses amounts to -32.8m EUR.
What is Vita 34 AG's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-17%
-17%
Over the last year, the Operating Expenses growth was 7%. The average annual Operating Expenses growth rates for Vita 34 AG have been -53% over the past three years , -27% over the past five years , and -17% over the past ten years .
You don't have any saved screeners yet
